5/2/2026•9 MIN READ
GLP-1 Agonists in Primary Care: New Cardiovascular Outcomes Data Changes the Prescribing Calculus
Extended follow-up data from the SELECT trial confirms cardiovascular mortality benefit in non-diabetic obese patients — and the practice management implications are significant.